Related Experiment Video
Updated: Nov 30, 2025

Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement
Published on: December 11, 2017
Long-term results after aortic valve replacement for bicuspid or tricuspid valve morphology in a Swedish population
Anders Holmgren1, Tone Bull Enger2, Ulf Näslund1
1Heart Centre and Department of Public Health and Clinical Medicine, Medicine, Umeå University, Umeå, Sweden.
Insights
Patients undergoing aortic valve replacement surgery with bicuspid morphology have better long-term survival. Combined surgery with coronary artery bypass grafting does not impact outcomes, offering valuable insights for aortic valve surgery planning.
Area of Science:
- Cardiovascular Surgery
- Medical Outcomes Research
Background:
- Aortic valve replacement (AVR) is a critical procedure for severe aortic valve disease.
- Understanding long-term survival based on valve morphology and surgical approach is essential for patient management.
Purpose of the Study:
- To evaluate long-term observed and relative survival after first-time AVR.
- To compare outcomes based on aortic valve morphology (bicuspid vs. tricuspid).
- To assess the impact of concomitant coronary artery bypass surgery (CABS) on survival.
Main Methods:
- A cohort of 5086 patients undergoing AVR between 2005-2016 from three Swedish hospitals was analyzed.
- Long-term survival (excluding 30-day mortality) was assessed using Cox regression and relative survival analysis.
- Multivariable analysis identified risk factors for long-term mortality.
Main Results:
- Long-term observed survival at 1, 5, and 10 years was 96.6%, 82.7%, and 57.6%, respectively.
- Relative survival rates at 1, 5, and 10 years were 99.0%, 97.5%, and 89.0% compared to the general population.
- Bicuspid aortic valve morphology was linked to improved long-term survival; concomitant CABS did not affect mortality.
Conclusions:
- Bicuspid aortic valve morphology is associated with a better long-term prognosis after AVR, comparable to the general population.
- Concomitant CABS during AVR does not negatively impact long-term survival.
- Age influences long-term relative survival favorably compared to the general Swedish population.
Objectives:
Our goal was to study long-term observed and relative survival after first-time aortic valve replacement surgery with or without concomitant coronary artery bypass surgery with reference to valve morphology (i.e. bicuspid vs tricuspid).
Methods:
Consecutive patients (n = 5086) from 3 Swedish hospitals, operated on between 1 January 2005 and 31 December 2016, were included. The 30-day mortality (n = 116, 2.3%) was excluded from the analysis of long-term observed and relative survival (n = 4970). Observed survival was analysed using Cox regression. Relative survival was calculated as the ratio between observed and expected survival based on data from the general Swedish population, matched for age, sex and calendar year. Risk factors for death were explored using multivariable analysis.
Results:
During the follow-up (median 4.7 years) period, 1157 (23%) patients died. Observed survival excluding 30-day mortality was 96.6%, 82.7% and 57.6% after 1, 5 and 10 years. Compared with the general Swedish population, the relative 1-, 5- and 10-year survival rates were 99.0%, 97.5% and 89.0%. Bicuspid morphology was independently associated with higher observed and relative long-term survival. Renal dysfunction, diabetes, chronic obstructive pulmonary disease, heart failure, smoking and atrial fibrillation were associated with higher long-term mortality. Combined surgery was not associated with higher observed or relative mortality.
Conclusions:
Patients with a bicuspid morphology had better prognosis, matching that of the general population. With increased age, long-term relative survival compared favourably with survival in the general Swedish population. Adding coronary artery bypass surgery to an aortic valve replacement procedure did not affect long-term outcome.
Related Concept Videos
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Aortic Regurgitation III: Medical Management

